How Disbrow was paid
$844,854 in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Joshua R. DisbrowChief Executive Officer | $608,154 | $42,750 | $177,000 | $16,950 | $844,854 |
| Ryan J. SelhornChief Financial Officer, Corporate Secretary and Treasurer | $432,462 | $33,250 | $84,000 | $16,500 | $566,212 |
| Jarrett T. DisbrowChief Business Officer | $398,135 | $23,750 | $96,563 | $15,931 | $534,379 |
| Greg PyszczymukaChief Commercial Officer | $434,300 | $23,750 | $84,357 | $16,511 | $558,918 |
What changed and why
- $845KCEO total compensation was $844,854 in 2026, compared with $883,928 in 2025.
- 50%Fiscal 2026 annual cash incentive awards were set at 50% of each NEO’s target opportunity and paid in fiscal 2027.
- $42,750Fiscal 2026 CEO compensation included $42,750 in stock awards and no option award value.
- The company says equity awards are intended to align executives’ interests with stockholders and incentivize stock-price appreciation.
Other AYTU Biopharma proxy statements
- 2025 proxy statement
Joshua R. Disbrow paid $883,928 (-5% on the year).
Filed Oct 24, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.